A patient is found to have a rare disease in which the secretory function of the alpha-cells of the pancreas is impaired. Direct stimulation of which of the following pathways in liver will be impaired?

Okay, let's tackle this question. The question is about a patient with impaired secretory function of pancreatic alpha-cells leading to a problem in the liver's pathway. First, I need to recall what the alpha-cells of the pancreas do. They produce glucagon, right? Glucagon's main role is to increase blood glucose levels by promoting glycogenolysis and gluconeogenesis in the liver. So if the alpha-cells are not working, glucagon secretion would be compromised.

Now, the question is asking which liver pathway is directly affected by this. The options aren't provided, but common pathways related to glucagon would include glycogenolysis (breaking down glycogen to glucose), gluconeogenesis (making glucose from non-carbs), glycolysis (breaking down glucose), and others like glycogenesis.

Since glucagon stimulates glycogenolysis and gluconeogenesis, if alpha-cells are impaired, the liver's ability to perform these two processes would be hindered. But the question is about which pathway's stimulation is impaired. So the correct answer would be the one that involves glucagon's action. Let's say the options were A) Glycolysis, B) Glycogenolysis, C) Glycogenesis, D) Lipogenesis. Then B would be correct because glycogenolysis is directly stimulated by glucagon.

Wait, but the options here are labeled A to D without text. But the correct answer is supposed to be one of them. Let me think again. The key here is that glucagon acts on the liver via the glucagon receptor (G protein-coupled receptor) to activate adenylyl cyclase, leading to cAMP increase, which activates protein kinase A. PKA then activates enzymes like phosphorylase kinase for glycogenolysis and inhibits glycolysis. So the direct pathway would be glycogenolysis and gluconeogenesis. If the question is about direct stimulation, glycogenolysis is the immediate response. So the correct answer would be the pathway related to glycogenolysis.

The wrong options might be glycolysis (which is inhibited by glucagon), glycogenesis (which is promoted by insulin), or lipogenesis (also insulin-dependent). So if the options are about those, the correct one is B (glycogenolysis) assuming the options are ordered accordingly.

So the core concept is glucagon's role in hepatic glycogenolysis. The correct answer is the pathway that's directly stimulated by glucagon, which is glycogenolysis. The incorrect options would be other pathways not directly stimulated by glucagon. The clinical pearl here is that glucagon deficiency would impair the liver's ability to release glucose during fasting, leading to hypoglycemia.

**Core Concept**
Alpha-cells of the pancreas secrete glucagon, a hormone that stimulates hepatic glycogenolysis and gluconeogenesis. Glucagon acts on liver cells via G-protein-coupled receptors to increase cAMP, activating protein kinase A (PKA) and triggering glucose release into the bloodstream.

**Why the Correct Answer is Right**
Glucagon deficiency impairs the liver’s ability to break down glycogen into glucose (glycogenolysis) and synthesize new glucose from non-carbohydrate sources (gluconeogenesis). These pathways are critical for maintaining blood glucose during fasting. The

✓ Correct Answer: C. Gluconeogenesis